Clinical Oncology
Volume 16, Issue 8 , Pages 536-542 , December 2004

Predictors of survival end points in patients with cancer of the cervix on long-term follow-up: inferences and implications from an audit of patients treated with a specific radiotherapy protocol

  • N.R. Datta

      Affiliations

    • Department of Radiotherapy, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
    • Corresponding Author InformationAuthor for correspondence: Dr Niloy Ranjan Datta, MD, DNB, Additional Professor and Head, Department of Radiotherapy, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Rae Barelli Road, Lucknow 226014, UP, India. Tel: +91-522-2668004 to 8/2668700, ext 2449; Fax: +91-522-2668017/2668973.
    • ,
  • R. Pasricha

      Affiliations

    • Department of Radiotherapy, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
    • ,
  • U. Singh

      Affiliations

    • Department of Biostatistics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
    • ,
  • A. Srivastava

      Affiliations

    • Department of Radiotherapy, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

Received 2 March 2004 ,Revised 27 May 2004 ,Accepted 2 June 2004.

References 

  1. Morris M, Eifel PJ, Lu J, et al.  Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340:1137–1143
  2. Peters WA, Liu PY, Barrett RJ, et al.  Concurrent chemotherapy and pelvic radiation therapy compared with radiotherapy alone as adjuvant therapy after radical surgery in high-risk early stage-cancer of the cervix. J Clin Oncol. 2000;18:1606–1613
  3. Rose PG, Bundy BN, Watkins EB, et al.  Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144–1153
  4. Whitney CW, Sause W, Bundy BN, et al.  Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB–IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 1999;17:1339–1348
  5. Keys HM, Bundy BN, Stehman FB, et al.  Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340:1154–1161
  6. National Cancer Institute . Clinical announcement: concurrent chemoradiation for cervical cancer. Washington, DC: Department of Public Health; February 1999;
  7. Green JA, Kirwan JM, Tierney JF, et al.  Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001;358:781–786
  8. Lukka H, Hirte H, Fyles A, et al.  Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer—a meta-analysis. Clin Oncol. 2002;14:203–212
  9. Pearcey R, Brundage M, Drouin P, et al.  Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol. 2002;20:966–972
  10. Brenna SM, Zeferino LC, Pinto GA, et al.  p53 expression as a predictor of recurrence in cervical squamous cell carcinoma. Int J Gynecol Cancer. 2002;12:299–303
  11. Takeda M, Sakuragi N, Okamoto K, et al.  Preoperative serum SCC, CA 125 and CA 19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix. Acta Obstet Gynecol Scand. 2002;81:451–457
  12. Graflund M, Sorbe B, Bryne M, Karlsson M. The prognostic value of a histological grading system, DNA profile, and MIB-1 expression in early stages of cervical squamous cell carcinomas. Int J Gynecol Cancer. 2002;12:149–157
  13. Brenna SM, Zeferino LC, Pinto GA, et al.  c-Myc protein expression is not an independent predictor in cervical squamous cell carcinoma. Braz J Med Biol Res. 2002;35:425–430
  14. West CM, Davidson SE, Roberts SA, Hunter RD. The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br J Cancer. 1997;76:1184–1190
  15. Dattoli MJ, Gretz HF, Beller U, et al.  Analysis of multiple prognostic factors in patients with stage IB cervical cancer; age as a major determinant. Int J Radiat Oncol Biol Phys. 1989;17:41–47
  16. Delaloye JF, Pampallona S, Coucke PA, De Grandi P. Younger age as a bad prognostic factor in patients with carcinoma of the cervix. Eur J Obstet Gynecol Reprod Biol. 1996;64:201–205
  17. Hirst DG. Anemia: a problem or an opportunity in radiotherapy?. Int J Radiat Oncol Biol Phys. 1986;12:2009–2017
  18. Toita T, Nakano M, Higashi M, Sakumoto K, Kanazawa K. Prognostic value of cervical size and pelvic lymph node status assessed by computed tomography for patients with uterine cervical cancer treated by radical radiation therapy. Int J Radiat Oncol Biol Phys. 1995;33:843–849
  19. Kapp KS, Stuecklschweiger GF, Kapp DS, et al.  Prognostic factors in patients of carcinoma of the uterine cervix treated with external beam irradiation and Ir-192 high-dose rate brachytherapy. Int J Radiat Oncol Biol Phys. 1998;42:531–540
  20. Chatani M, Matayoshi Y, Masaki N, Inoue T. High dose intracavitary irradiation for carcinoma of the uterine cervix; the adverse effect of treatment prolongation. Strahlenther Onkol. 1997;173:379–384
  21. Das KR, Shanta A, Kulkarni RN, Shah PK. Ralstron 20B: a high dose rate remote controlled afterloader for brachytherapy. Endocurie Hyperthermia Oncol. 1987;3:81–89
  22. Hong JH, Chen MS, Lin F, Tang SG. Prognostic assessment of tumor regression after external irradiation for cervical cancer. Int J Radiat Oncol Biol Phys. 1992;22:913–917
  23. Kaplan ES, Meier PJ. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
  24. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187–202
  25. Waggoner SE. Cervical cancer. Lancet. 2003;361:2217–2225
  26. Rose PG. Chemoradiotherapy for cervical cancer. Eur J Cancer. 2002;38:270–278
  27. Maduro JH, Pras E, Willemse PHB, de Vries EGE. Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat Rev. 2003;29:471–488
  28. Grau C, Agarwal JP, Jabeen K, et al.  Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA multicentre randomised trial. Radiother Oncol. 2003;67:17–26
  29. Annual Report on the Results of Treatment in Gynecological Cancer. J Epidemiol Stat. 1998;3:5–34
  30. Chen SW, Liang JA, Yang SN, Ko HL, Lin FJ. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy. Radiother Oncol. 2003;67:69–76
  31. Karolewski K, Korzeniowski S, Sokolowski A, Urbanski K, Kojs Z. Prognostic significance of pretherapeutic and therapeutic factors in patients with advanced cancer of the uterine cervix treated with radical radiotherapy alone. Acta Oncol. 1999;38:461–468
  32. Takeshi K, Katsuyuki K, Yoshiaki T, et al.  Definitive radiotherapy combined with high-dose-rate brachytherapy for stage III carcinoma of uterine cervix: retrospective analysis of prognostic factors concerning patient characteristics and treatment parameters. Int J Radiat Oncol Biol Phys. 1998;41:319–327
  33. Orton CG, Seyedsadr M, Somnay A. Comparison of high and low dose-rate remote afterloading for cervix cancer and the importance of fractionation. Int J Radiat Oncol Biol Phys. 1991;21:1425–1434
  34. Fyles A, Keane TJ, Barton M, Simm J. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol. 1992;25:273–279
  35. Kapp DS, Giaccia AJ. New directions for radiation biology research in cancer of the uterine cervix. J Natl Cancer Inst Monogr. 1996;21:131–139
  36. Peters L, McKay M. Predictive assays: will they ever have a role in the clinic?. Int J Radiat Oncol Biol Phys. 2001;49:504–510

PII: S0936-6555(04)00220-1

doi: 10.1016/j.clon.2004.06.005

Clinical Oncology
Volume 16, Issue 8 , Pages 536-542 , December 2004

Article Tools

* Image Usage & Resolution